Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer.
Apr 2010 - :1432-1440 [PMID:20393691]
[Song KY] [Wong J] [Gonzalez L] [Sheng G] [Zamarin D] [Fong Y]

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses.
Apr 2009 - Mol. Ther.; 17(4):1525-0024 [PMID:19209145]
[Zamarin D] [Martínez-Sobrido L] [Kelly K] [Mansour M] [Sheng G] [Vigil A] [García-Sastre A] [Palese P] [Fong Y]